Abstract:Objective To investigate the technological feasibility,efficacy and morbidity of ~(125)I-seed implantation for head and neck cancer. Methods Forty patients with head and neck cancer were treated with ~(125)I-seed intersitial brachytherapy guided by ultrasound or CT.Among them thirty-six patients were performed under local anesthesia and four were under general anesthesia.Thirty-six patients were treated with ~(125)I-seed implantation under ultrasound guidance and four cases under CT guidance.Seed needles were implanted in parallel with each other,1-1.5 cm apart.Mick applicator was used to each needle to implant seed.The radioactive activity ranged 0.40-0.70 mCi,and the matched peripheral doses were 90-145 Gy.The mean number of ~(125)I-seed was 3-84.Five cases received external beam irradiation one week after seed implantation,and the total doses were 45-50 Gy(200 cGy/f).All the cases were examined by X-ray or CT after implantation for quality evaluation and by routine chest X ray within twenty-four to forty-eight hours after seed implantation. Results These patients were followed-up for 3-33 months.In 10 tongue carcinoma patients,complete response was shown in 3 cases,partial response in three cases,no change in three cases and progressive disease in one case.The local control rate was 60%,the median survival time was 11 monthes,and the one-year and two year survival rates were 87.50% and 35%,respectively.In 14 patients with recurrent cancer of head and neck the local control rate was 76.47%,the one-year and two-year survival rates were 66.08% and 24%,respectively,and the median survival time was 9 months.In 16 patients with metastatic cancer of head and neck the local control rate was 95.23%,the one-year and two-year survival rates were 54.55% and 32.73%,and the median survival time was 9 months.One seed migrated to the maxilla and loss of seeds happened in two cases,but there was no clinically related mobidity. Conclusion ~(125)I-seed implantation for recurrent or metastatic head and neck cancer under guidance of ultrasound or CT is safe,minimal invasive,with low morbidity and high efficacy,especially for recurrent and matastatic cancer of head and neck after surgery or radiotherapy.

[Permanent Interstitial Implantation of 125I Seeds for 5 Cases of Advanced Head and Neck Cancer].

Permanent Implantation of 125I Seeds As a Salvage Therapy for Head and Neck Carcinoma after Radiotherapy

5 Year Outcome of Ultrasound-Guided Interstitial Permanent 125i Seeds Implantation for Local Recurrent Tumor of Head and Neck

Five-year outcome of ultrasound-guided interstitial permanent 125 I seeds implantation for local head and neck recurrent tumors: a single center retrospective study.

Implantation of Iodine-125 Seed for Head and Neck Carcinoma

CT-guided Iodine-125 Seed Permanent Implantation for Recurrent Head and Neck Cancers

Permanent Implantation of Iodine-125 Seeds As a Salvage Therapy for Recurrent Head and Neck Carcinoma after Radiotherapy

An Investigation of 125I Seed Permanent Implantation for Recurrent Carcinoma in the Head and Neck after Surgery and External Beam Radiotherapy

[Short- to Mid-Term Evaluation of CT-guided 125I Brachytherapy on Recurrent or Metastatic Head and Neck Cancers].

[Ultrasound Guided Implantation of Radioactive (125)I Seeds for Treatment of Recurrent Head and Neck Carcinomas].

Interstitial implantation of ~(125)I seeds for the treatment of soft tissue tumors

~(125)I seeds interstitial brachytherapy for vertebral and paraspinal carcinomas

Percutaneous Computed Tomography/ultrasonography-Guided Permanent Iodine-125 Implantation As Salvage Therapy for Recurrent Squamous Cell Cancers of Head and Neck

Percutaneous Image-Guided Permanent 125 I Implantation for Treating Recurrent Head and Neck Cancer, 2000-2015

Combined External Radiotherapy and 125I-Particle Implantation for Treatment of Head and Neck Cancers

CT-guided Implantation of Interstitial 125I Seed for Brachytherapy of Recurrent Head and Neck Tumor

Efficacy of radioactive 125I seed implantation in treating inoperable or refused operation head and neck cancers

Permanent 125I Seeds Implantation in Cancers Report of 85 Cases)

Computed Tomography Fluoroscopy-Guided Percutaneous 125I Seed Implantation for Safe, Effective and Real-Time Monitoring Radiotherapy of Inoperable Stage T1-3N0M0 Non-Small-cell Lung Cancer.

Treatment of advanced pancreatic adenocarcinoma with implantation of radioactive 125I under the guidance of ultrasound

Computed Tomography (Ct)-Guided Interstitial Permanent Implantation of (125)I Seeds for Refractory Chest Wall Metastasis or Recurrence.